MoonLake Immunotherapeutics (MLTX)
Nasdaq · Pharmaceutical Preparations · Inc. E9
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 3 signals for MoonLake Immunotherapeutics. Most notable: 2026-06-25: Filed 8-K disclosing material agreement; 2026-07-10: Santos da Silva Jorge (director) sold $1.4M of stock; 2026-07-21: Reich Kristian (officer) sold $1.0M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Large insider saleReich Kristian (officer) sold $1.0M of stock
- Large insider saleSantos da Silva Jorge (director) sold $1.4M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Large insider saleSantos da Silva Jorge (director) sold $1.8M of stock
- Large insider saleBodenstedt Matthias (officer) sold $1.6M of stock
- Large insider saleBodenstedt Matthias (officer) sold $1.6M of stock
- Large insider saleLAMPERT MARK N (director) sold $32.4M of stock
- Large insider saleLAMPERT MARK N (director) sold $26.3M of stock
- Large insider saleLAMPERT MARK N (director) sold $4.2M of stock
- Material 8-K filingFiled 8-K disclosing material agreement, director or officer change
- Large insider saleReich Kristian (officer) sold $1.1M of stock
- Large insider saleSantos da Silva Jorge (director) sold $1.0M of stock
- Large insider saleReich Kristian (officer) sold $2.0M of stock
- Large insider saleSantos da Silva Jorge (director) sold $2.0M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Insider purchaseBodenstedt Matthias (officer) bought $99k of stock
- Large insider saleChen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP (other) sold $25.7M of stock
- Large insider saleCormorant Global Healthcare Master Fund, LP (other) sold $25.7M of stock
- Large insider saleCormorant Global Healthcare Master Fund, LP (other) sold $18.5M of stock
- Large insider saleChen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP (other) sold $2.0M of stock
- Large insider saleCormorant Global Healthcare Master Fund, LP (other) sold $2.0M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-27 | Reich Kristian | officer | S | 1,100 | 20 | $22,000 |
| 2026-07-22 | Reich Kristian | officer | S | 2,448 | 20 | $48,960 |
| 2026-07-21 | Reich Kristian | officer | S | 50,000 | 20.02 | $1,001,000 |
| 2026-07-20 | Reich Kristian | officer | S | 43,700 | 20.09 | $877,933 |
| 2026-07-15 | Reich Kristian | officer | S | 16,105 | 20.01 | $322,261 |
| 2026-07-10 | Santos da Silva Jorge | director | S | 68,289 | 20.02 | $1,367,146 |
| 2026-07-09 | Santos da Silva Jorge | director | S | 33,936 | 20.01 | $679,059 |
| 2026-07-01 | Santos da Silva Jorge | director | S | 47,775 | 20.03 | $956,933 |
| 2026-06-22 | Bodenstedt Matthias | officer | S | 39,120 | 22.04 | $862,205 |
| 2026-06-22 | Bodenstedt Matthias | officer | S | 39,120 | 22.04 | $862,205 |
| 2026-06-18 | Bodenstedt Matthias | officer | S | 2,794 | 19.6 | $54,762 |
| 2026-06-18 | Bodenstedt Matthias | officer | S | 2,794 | 19.6 | $54,762 |
| 2026-06-17 | Bodenstedt Matthias | officer | S | 15,082 | 19.68 | $296,814 |
| 2026-06-17 | Reich Kristian | officer | S | 50,000 | 19.43 | $971,500 |
| 2026-06-17 | Bodenstedt Matthias | officer | S | 15,082 | 19.68 | $296,814 |
| 2026-06-17 | Reich Kristian | officer | S | 50,000 | 19.43 | $971,500 |
| 2026-06-16 | Reich Kristian | officer | S | 50,000 | 18.7 | $935,000 |
| 2026-06-16 | Reich Kristian | officer | S | 50,000 | 18.7 | $935,000 |
| 2026-06-15 | Reich Kristian | officer | S | 50,000 | 18.89 | $944,500 |
| 2026-06-15 | Reich Kristian | officer | S | 50,000 | 18.89 | $944,500 |
| 2026-05-11 | Bodenstedt Matthias | officer | S | 13,653 | 20.02 | $273,333 |
| 2026-05-11 | Bodenstedt Matthias | officer | S | 13,653 | 20.02 | $273,333 |
| 2026-04-14 | Bodenstedt Matthias | officer | S | 2,426 | 19.56 | $47,453 |
| 2026-04-14 | Bodenstedt Matthias | officer | S | 2,426 | 19.56 | $47,453 |
| 2026-04-13 | Santos da Silva Jorge | director | S | 51,873 | 18.23 | $945,645 |
| 2026-04-13 | Santos da Silva Jorge | director | S | 51,873 | 18.23 | $945,645 |
| 2026-04-10 | Santos da Silva Jorge | director | S | 98,127 | 18.41 | $1,806,518 |
| 2026-04-10 | Bodenstedt Matthias | officer | S | 1,925 | 19.51 | $37,557 |
| 2026-04-10 | Santos da Silva Jorge | director | S | 98,127 | 18.41 | $1,806,518 |
| 2026-04-10 | Bodenstedt Matthias | officer | S | 1,925 | 19.51 | $37,557 |
| 2026-04-09 | Bodenstedt Matthias | officer | S | 85,870 | 18.94 | $1,626,378 |
| 2026-04-09 | Bodenstedt Matthias | officer | S | 85,870 | 18.94 | $1,626,378 |
| 2026-03-31 | LAMPERT MARK N | director | S | 1,932,354 | 16.79 | $32,444,224 |
| 2026-03-31 | LAMPERT MARK N | director | S | 1,569,116 | 16.79 | $26,345,458 |
| 2026-03-31 | LAMPERT MARK N | director | S | 248,530 | 16.79 | $4,172,819 |
| 2026-03-31 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | director | S | 1,932,354 | 16.79 | $32,444,224 |
| 2026-03-31 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | director | S | 1,569,116 | 16.79 | $26,345,458 |
| 2026-03-31 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | director | S | 248,530 | 16.79 | $4,172,819 |
| 2026-01-07 | Bodenstedt Matthias | officer | A | 354,296 | 0 | $0 |
| 2026-01-07 | Bodenstedt Matthias | officer | A | 354,296 | 0 | $0 |
| 2025-12-19 | Bodenstedt Matthias | officer | C | 294,473 | — | — |
| 2025-12-19 | Bodenstedt Matthias | officer | D | 294,473 | — | — |
| 2025-12-19 | Reich Kristian | officer | D | 35,389 | — | — |
| 2025-12-19 | Reich Kristian | officer | C | 35,389 | — | — |
| 2025-12-19 | Santos da Silva Jorge | director | D | 196,316 | — | — |
| 2025-12-19 | Santos da Silva Jorge | director | C | 196,316 | — | — |
| 2025-12-19 | Bodenstedt Matthias | officer | C | 294,473 | — | — |
| 2025-12-19 | Bodenstedt Matthias | officer | D | 294,473 | — | — |
| 2025-12-19 | Reich Kristian | officer | C | 35,389 | — | — |
| 2025-12-19 | Reich Kristian | officer | D | 35,389 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-10 S-8
- 2026-08-10 S-3ASR
- 2026-08-10 10-Q
- 2026-08-10 8-K
- 2026-07-29 4
- 2026-07-23 4
- 2026-07-21 4
- 2026-07-20 4
- 2026-07-15 144
- 2026-07-15 8-K
- 2026-07-13 4
- 2026-07-02 4
- 2026-06-30 144
- 2026-06-29 SCHEDULE 13D/A
- 2026-06-25 8-K
- 2026-06-24 424B5
- 2026-06-23 4